Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
about
A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies.Acridine and its derivatives: a patent review (2009 - 2013).Immunotherapy in acute myeloid leukemia.FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes.Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.
P2860
Q37694704-F3173A2C-33CC-40FC-AEF6-01C0ED8524BCQ38213469-E355C8BE-D72B-436B-B4D8-77A6C3B2D8FEQ38533606-D0E4C8F9-CC99-44C8-AF25-2FC3B80636CAQ40777838-242C0147-51C0-42F7-9DF2-CB7CF7EB3CBBQ40971755-1F861C4D-B584-4DD0-B68C-C455CA6D197CQ41138074-895D3215-C090-4647-BD32-374F0E562649Q47598339-1A7A935A-97B9-4397-B0FA-4B831DD5C3E4
P2860
Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@ast
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@en
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@nl
type
label
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@ast
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@en
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@nl
prefLabel
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@ast
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@en
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
Combination of fludarabine, am ...... h-risk acute myeloid leukemia.
@en
P2093
Jaroslav Dusek
Jiri Mayer
Marta Krejci
Michael Doubek
Milan Navratil
Miroslav Tomiska
Ondrej Horky
Sarka Pospisilova
Yvona Brychtova
Zdenek Racil
P2860
P304
P356
10.1007/S00277-013-1790-5
P577
2013-06-01T00:00:00Z